The Metabolomics of Parkinson's Disease | Panome Bio

White Paper

Global metabolomics, when applied to Parkinson’s Disease research, has the potential to make a significant impact in biomarker development, whether for susceptibility, diagnosis, pharmacodynamic response or prognostic assessment of disease. And even beyond biomarkers, Next- Generation Metabolomics from Panome Bio opens doors to understanding molecular mechanisms and signaling pathways involved in PD.

Download Now

Your privacy is important to us.
We'll never share your information.

Skip to content